Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases
IF=10.3
Journal for Immunotherapy of Cancer
Author: Chandra C Ghosh, Lauren Cournoyer, Yujia Liu
Deterministic Single-Cell Encapsulation in PEG Norbornene Microgels for Promoting Anti-Inflammatory Response and Therapeutic Delivery of Mesenchymal Stromal Cells
Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases
IF=10.3
Journal for Immunotherapy of Cancer
Author: Chandra C Ghosh, Lauren Cournoyer, Yujia Liu
Deterministic Single-Cell Encapsulation in PEG Norbornene Microgels for Promoting Anti-Inflammatory Response and Therapeutic Delivery of Mesenchymal Stromal Cells
Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases
IF=10.3
Journal for Immunotherapy of Cancer
Author: Chandra C Ghosh, Lauren Cournoyer, Yujia Liu
Deterministic Single-Cell Encapsulation in PEG Norbornene Microgels for Promoting Anti-Inflammatory Response and Therapeutic Delivery of Mesenchymal Stromal Cells
Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases
IF=10.3
Journal for Immunotherapy of Cancer
Author: Chandra C Ghosh, Lauren Cournoyer, Yujia Liu
Deterministic Single-Cell Encapsulation in PEG Norbornene Microgels for Promoting Anti-Inflammatory Response and Therapeutic Delivery of Mesenchymal Stromal Cells
Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases
IF=10.3
Journal for Immunotherapy of Cancer
Author: Chandra C Ghosh, Lauren Cournoyer, Yujia Liu
Deterministic Single-Cell Encapsulation in PEG Norbornene Microgels for Promoting Anti-Inflammatory Response and Therapeutic Delivery of Mesenchymal Stromal Cells
By subscription, you consent to allow Ubigene Biosciences to store and process the information
provided above to deliver the latest news, research spotlight, and promotions. You can unsubscribe
from these communications at anytime.